Drugs / AC133
last change Dec 2012 re-read 3 minutes ago

AC133

Cell therapy

Developed for
myocardial infarction
Investigated by
Royan Institute

Trials 2

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/31 trial
Phase 2/3 NCT01187654 May 2009 → Sep 2012 myocardial infarction Royan Institute Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01167751 Jan 2008 → Jun 2012 myocardial infarction Royan Institute Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as AC133 “Implantation of BM derived AC133” NCT01167751 ↗
2

NCT01187654 ↗

NCT01167751 ↗

Modality Cell therapy “bone marrow derived AC133+ cells” NCT01187654 ↗
Route Other “intra coronary injection” NCT01187654 ↗